Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells

Blood

Volumn 75, Issue 10, 1990, Pages 1947-1950

  Kastan, Michael B ^a,b   Schlaffer, Eileen ^a   Russo, James E ^a   Colvin, O Michael ^a   Civin, Curt I ^a   Hilton, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANTIBODY; CYCLOPHOSPHAMIDE;

ANIMAL; ARTICLE; CELL LINE; CYTOPLASM; ENZYMOLOGY; EXPERIMENTAL LEUKEMIA; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; LEUKEMIA L 1210; METABOLISM; MOUSE; MYELOID LEUKEMIA; PATHOLOGY; WESTERN BLOTTING;

ALDEHYDE DEHYDROGENASE; ANIMAL; ANTIBODIES; BLOTTING, WESTERN; CELL LINE; CYCLOPHOSPHAMIDE; CYTOPLASM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMAN; LEUKEMIA L1210; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID; MICE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025707866     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v75.10.1947.1947     Document Type: Article

References (14)

1. Yeager AW, Kaiser H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davic JM, Karp JE, May WS, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR: Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141, 1986
2. Hilton J: Role of aldehyde dehydrogenase in cyclophosphamide resistant L1210 leukemia. Cancer Res 44:5156, 1984
3. Sladek NE, Landkamer GL: Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Cancer Res 45:1549, 1985
4. Russo JE, Hilton J: Characterization of cytosolic aldehyde dehydrogenase from cyclophospnamide resistant L1210 cells. Cancer Res 48:2963, 1988
5. Sladek NE: Evidence for an aldehyde possessing alkylating activity as the primary cytotoxic metabolite of cyclophosphamide. Cancer Res 33:651, 1973
6. Cox PJ, Phillips BJ, Thomas P: The enzymic basis of the selective action of cyclophosphamide. Cancer Res 35:3755, 1975
7. Russo JE, Hilton J, Colvin OM: The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide, in Weiner H, Flynn TG (eds): Enzymology and Molecular Biology of Carbonyl Metabolism 2. New York, NY, Liss, 1989, p 65
8. Kohn FR, Sladek NE: Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (Asta Z 7557). Biochem Pharmacol 36:2805, 1987
9. Sahovic EA, Colvin OM, Hilton J, Ogawa M: Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro. Cancer Res 48:1223, 1988
10. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
11. Kastan MB, Slamon DJ, Civin CI: Expression of protooncogene c-myb in normal human hematopoietic cells. Blood 73:144, 1989
12. Kastan MB, Stone KD, Civin CI: Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferation status of normal human hematopoietic cells. Blood 74:1517, 1989
13. Inoue K, Nishimukai N, Yamasawa K: Purification and partial characterization of aldehyde dehydrogenase from human erythrocytes. Biochim Biophys Acta 569:117, 1979
14. Strauss LC, Rowley SD, LaRussa VF, Sharkis SJ, Stuart RK, Civin CI: Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878, 1986